A detailed history of Cibc Private Wealth Group, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 750 shares of EOLS stock, worth $12,607. This represents 0.0% of its overall portfolio holdings.

Number of Shares
750
Previous 750 -0.0%
Holding current value
$12,607
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$9.99 - $14.91 $7,492 - $11,182
750 New
750 $10,000
Q3 2018

Nov 14, 2018

SELL
$17.31 - $29.82 $9,087 - $15,655
-525 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$6.85 - $38.49 $3,596 - $20,207
525 New
525 $15,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $943M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.